These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38960049)

  • 21. Relationship of single and co-exposure of per-and polyfluoroalkyl substances and their alternatives with uric acid: A community-based study in China.
    Liang LX; Lin LZ; Zeeshan M; Zhou Y; Tang YX; Chu C; Zhang YT; Liu RQ; Feng W; Dong GH
    J Hazard Mater; 2024 Mar; 466():133500. PubMed ID: 38266584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentrations and association between exposure to mixed perfluoroalkyl and polyfluoroalkyl substances and glycometabolism among adolescents.
    Yan W; Bai R; Zheng Q; Yang X; Shi Y; Yang R; Jiang C; Wang X; Li X
    Ann Med; 2023 Dec; 55(1):2227844. PubMed ID: 37354023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to perfluoroalkyl substances in early pregnancy and the risk of hypertensive disorders of pregnancy: A nested case-control study in Guangxi, China.
    Liu B; Wei B; Mo M; Song Y; Tang C; Tang P; Guo X; Tan C; Liu S; Huang D; Qiu X
    Chemosphere; 2022 Feb; 288(Pt 1):132468. PubMed ID: 34624345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of organophosphate esters (OPEs) and polyfluoralkyl substances (PFASs) in settled dust in specific workplaces.
    Sonego E; Simonetti G; Di Filippo P; Riccardi C; Buiarelli F; Fresta A; Olivastri M; Pomata D
    Environ Sci Pollut Res Int; 2022 Jul; 29(34):52302-52316. PubMed ID: 35258734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum albumin mediates the effect of multiple per- and polyfluoroalkyl substances on serum lipid levels.
    Fan Y; Li X; Xu Q; Zhang Y; Yang X; Han X; Du G; Xia Y; Wang X; Lu C
    Environ Pollut; 2020 Nov; 266(Pt 2):115138. PubMed ID: 32717635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association among serum per- and polyfluoroalkyl substances, lipid profile and metabolic syndrome in Czech adults, HBM-EHES survey 2019.
    Puklová V; Čapková N; Fialová A; Vavrouš A; Žejglicová K; Černá M
    Cent Eur J Public Health; 2023 Dec; 31(4):227-234. PubMed ID: 38309699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of organophosphate ester exposure with cardiovascular disease among US adults: Cross-sectional findings from the 2011-2018 National Health and Nutrition Examination Survey.
    Guo X; Wu B; Xia W; Gao J; Xie P; Feng L; Sun C; Liang M; Ding X; Zhao D; Ma S; Liu H; Lowe S; Bentley R; Huang C; Qu G; Sun Y
    Chemosphere; 2022 Dec; 308(Pt 2):136428. PubMed ID: 36115470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organophosphate esters, airway inflammation, and lung function among U.S. participants: A nationally representative cross-sectional study from NHANES, 2011-2012.
    Hu P; Ke S; Vinturache A; Chen Y; Ding G; Zhang Y
    Sci Total Environ; 2023 Sep; 892():164755. PubMed ID: 37301401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In utero exposure to per-/polyfluoroalkyl substances (PFASs): Preeclampsia in pregnancy and low birth weight for neonates.
    Tian Y; Zhou Q; Zhang L; Li W; Yin S; Li F; Xu C
    Chemosphere; 2023 Feb; 313():137490. PubMed ID: 36513200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between perfluoroalkyl and polyfluoroalkyl substances exposure and fetal overgrowth: A prospective birth cohort study conducted in China.
    Pan D; Song Y; Liu S; Zeng X; Pang Q; Zhang Y; Wu H; Tan HJJ; Liao Q; Liang J; Huang D; Qiu X
    Environ Res; 2023 Sep; 232():116175. PubMed ID: 37257750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum concentrations of per-/polyfluoroalkyl substances and risk of type 2 diabetes: A case-control study.
    Duan Y; Sun H; Yao Y; Li Y; Meng Y; Lu Y; Han L; Chen L
    Sci Total Environ; 2021 Sep; 787():147476. PubMed ID: 33992947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between prenatal exposure to perfluoroalkyl substances and anogenital distance in female neonates.
    Li J; Yang L; He G; Wang B; Miao M; Ji H; Wen S; Cao W; Yuan W; Liang H
    Ecotoxicol Environ Saf; 2022 Oct; 245():114130. PubMed ID: 36182800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of per- and polyfluoroalkyl substances alternatives and blood pressure by sex status: Isomers of C8 health project in China.
    Mi X; Yang YQ; Zeeshan M; Wang ZB; Zeng XY; Zhou Y; Yang BY; Hu LW; Yu HY; Zeng XW; Liu RQ; Dong GH
    Chemosphere; 2020 Dec; 261():127691. PubMed ID: 32717511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individual and joint associations of per- and polyfluoroalkyl substances (PFAS) with gallstone disease in adults: A cross-sectional study.
    Shi T; Li D; Li D; Sun J; Xie P; Wang T; Li R; Li Z; Zou Z; Ren X
    Chemosphere; 2024 Jun; 358():142168. PubMed ID: 38685323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.
    Zhan W; Qiu W; Ao Y; Zhou W; Sun Y; Zhao H; Zhang J
    Environ Health Perspect; 2023 May; 131(5):57001. PubMed ID: 37134253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure to novel and legacy per- and polyfluoroalkyl substances (PFASs) and associations with type 2 diabetes: A case-control study in East China.
    Han X; Meng L; Zhang G; Li Y; Shi Y; Zhang Q; Jiang G
    Environ Int; 2021 Nov; 156():106637. PubMed ID: 33993001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal exposure to poly/perfluoroalkyl substances and risk for congenital heart disease in offspring.
    Li S; Wang C; Yang C; Chen Y; Cheng Q; Liu J; Zhang Y; Jin L; Li Z; Ren A; Wang L
    J Hazard Mater; 2024 May; 469():134008. PubMed ID: 38503211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between serum per- and polyfluoroalkyl substances concentrations and common cold among children and adolescents in the United States.
    Zhang Y; Mustieles V; Sun Y; Oulhote Y; Wang YX; Messerlian C
    Environ Int; 2022 Jun; 164():107239. PubMed ID: 35447424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.